Refeeding Syndrome

Refeeding syndrome is a potentially life threatening metabolic disturbance that can occur when nutritional support (oral, enteral or parenteral) is reintroduced too rapidly in a significantly malnourished individual. It is characterised by severe electrolyte shifts, particularly hypophosphataemia, together with hypokalaemia, hypomagnesaemia and fluid retention.

The mechanism is a shift from a predominantly catabolic, fat and protein based metabolic state during starvation to an anabolic, carbohydrate based state on refeeding.

Recognising at risk individuals and using a cautious, structured refeeding protocol is an essential, preventable safety measure wherever significant malnutrition is present. This includes, but is not limited to, nutritional rehabilitation of patients with anorexia nervosa and other significantly restrictive eating disorders.

Pathophysiology

• During prolonged starvation or significant caloric restriction, the body shifts to a catabolic state that uses fat and protein stores for energy. Insulin secretion is suppressed by the low carbohydrate intake.
• Total body phosphate, potassium and magnesium become significantly depleted. Serum levels frequently remain within, or close to, the normal range, because compensatory mechanisms maintain serum concentration despite substantial total body depletion.
• On reintroduction of carbohydrate based nutrition, a surge in insulin secretion drives cellular uptake of glucose together with phosphate, potassium and magnesium. Serum concentrations of these electrolytes fall rapidly, sometimes severely, as they shift intracellularly, unmasking the previously compensated total body depletion.
• Hypophosphataemia is the most clinically dangerous and characteristic biochemical hallmark. Phosphate is critical to numerous cellular processes, including adenosine triphosphate synthesis.
• Severe hypophosphataemia, with the associated hypokalaemia and hypomagnesaemia, produces the clinical manifestations of refeeding syndrome.
• Cardiac dysfunction and arrhythmia reflect both the electrolyte disturbance and the added stress of sudden fluid and sodium retention, caused by the renal sodium retaining effect of the insulin surge.
• Respiratory muscle weakness reflects the dependence of respiratory muscle function on adequate cellular energy availability. The most severe cases develop multi-organ dysfunction.

• Cardiac manifestations are the most immediately life threatening. They include arrhythmia, heart failure and, in the most severe cases, cardiac arrest. Heart failure reflects both direct myocardial dysfunction from severe hypophosphataemia and the fluid overload from the sodium and water retention characteristic of the syndrome.
• Respiratory muscle weakness may progress to respiratory failure in severe cases.
• Generalised muscle weakness, rhabdomyolysis, confusion and, in severe hypophosphataemia, seizures reflect the broader neuromuscular and neurological consequences of the electrolyte disturbance.
• Peripheral oedema reflects the sodium and fluid retention associated with the insulin surge and refeeding. In severe cases fluid overload is more significant, with pulmonary oedema. Monitor fluid balance carefully throughout refeeding.
• The syndrome typically develops within the first several days of nutritional reintroduction. Timing and severity reflect the degree of pre-existing malnutrition and the rate of caloric reintroduction.
• Close, proactive monitoring during this early period is essential in all at risk patients.

• Identifying individuals at significant risk is the essential first step, using established risk criteria. These include significantly low body mass index, significant recent unintentional weight loss, minimal or no nutritional intake for a prolonged period, and low baseline serum potassium, phosphate or magnesium.
• Multiple risk factors, or a single severe risk factor, indicate particularly high risk and call for the most cautious refeeding approach.
• Assess baseline electrolytes (phosphate, potassium, magnesium, together with glucose and renal function) before commencing nutritional support.
• Then monitor the same parameters closely and frequently through the initial refeeding period: typically at least daily for the first several days, and more often in the highest risk patients.
• The syndrome is defined and identified by this pattern of electrolyte derangement developing after nutritional reintroduction following a period of significant malnutrition.
• Cardiac monitoring supports identification of cardiac and fluid related complications. Use electrocardiography and, in higher risk or more unwell patients, continuous cardiac monitoring, together with structured fluid balance assessment.

• Prevention through cautious, structured, gradual caloric reintroduction is the essential, primary management strategy.
• Current guidance favours a more cautious, though not excessively restrictive, starting caloric intake in high risk individuals than historical practice. Recommended starting levels vary somewhat between protocols, but are generally in the range of 5 to 10 kilocalories per kilogram per day in the highest risk patients. Increase gradually over subsequent days, guided by clinical and biochemical response.
• This reflects the balance between the risks of significant underfeeding, with its own complications, and the risks of overly rapid, aggressive refeeding.
• Give prophylactic electrolyte supplementation, particularly phosphate, proactively in high risk patients rather than waiting for biochemical derangement.
• Give thiamine supplementation as well, before or alongside the start of refeeding in at risk individuals. Carbohydrate reintroduction in a thiamine deficient individual carries a separate risk of precipitating Wernicke encephalopathy.
• Monitor electrolytes, fluid balance and clinical status closely through the initial refeeding period. Correct any electrolyte derangement promptly as it develops, following standard replacement principles for the electrolyte affected.
• Titrate the caloric reintroduction rate carefully to ongoing clinical and biochemical response.
• If significant refeeding syndrome develops despite prevention, temporarily reduce caloric intake or, in severe cases, briefly interrupt it. Correct the identified electrolyte derangements aggressively and give full supportive care for cardiac, respiratory or neurological complications.
• Deliver care in a setting resourced to the severity of the presentation, with cardiac monitoring. Significant cardiac or respiratory compromise in the most severe cases requires intensive care support.
• Careful, proactive application of the structured refeeding approach is particularly essential in nutritional rehabilitation of patients with anorexia nervosa and other significantly restrictive eating disorders. This is one of the most important and frequently encountered contexts in which the syndrome must be anticipated and prevented.
• Other relevant populations include patients with chronic alcohol use disorder, prolonged fasting or inadequate nutritional intake from any cause, and certain oncology patients with significant pre-existing malnutrition.